We performed a myogenic differentiation time-course experiment to examine the expression profile of PTPN1/2 and the phosphorylation status of their substrate STAT3 in DMD patient-derived and unaffected control human MuSCs. This evidence concerns the gene PTPN1 and Duchenne muscular dystrophy.